cytotoxic T cells (CTL) requires interaction with HLA class I polymorphisms, such engagement turns natural killer (NK) cells off. These contrasting mechanisms give complementarily to NK and CTL responses. The overall goal of this research is to understand the interaction of human T-cell receptors and NK cell receptors with HLA class I, and the modulation in specificity and function caused by natural HLA polymorphism. Investigation is focused on HLA-B, the locus most clearly implicated in both CTL and NK function.
Aim 1 determines the effects that polymorphisms within the diverse family of HLA-B15 allotypes have upon peptide binding specificity, the repertoire of endogenous peptides bound and the stimulation of alloreactive CTL. One family member (B*4601) has an HLA-C derived motif, which causes it to interact with NK cell receptors like an HLA-C allotype and to have an unprecedented bias for binding 3 cellular peptides. The basis for these unusual properties will be determined.
Aim 2 will define the HLA class I determinants recognized by the NK cell receptors and the effects of HLA types on the NK cell repertoire. Through comparison of natural and mutant HLA-B allotypes the specificity of the NKB1 receptor, which correlates with the Bw4 serological epitope, will be determined. The role of bound peptide in creating the inhibitory determinant will be assessed. The expression of class I receptors by the NK cells and T cells of unrelated donors and family members with different HLA-A,B,C type will be compared. For selected donors, a panel of NK cell clones will be characterized for their specificity of class I inhibition and expression of class I receptors. Predictions of the 'Missing Self' model will be tested.
Aim 3 will determine the mechanism by which engagement of a receptor by a complementary class I ligand leads to 'turning off' of the NK cell. The 'Effector Inhibition' model will be tested. Pathways of signal transduction will be compared in NKB1+ NK cells confronted with target cells expressing either Bw4+ or Bw4- HLA-B molecules. Changes found in tyrosine phosphorylation provide one basis for further study. The effects of class I engagement on Fc receptor mediated lysis and cytokine secretion, and of cross-linking the NKB1 receptor with specific antibody will be studied. Comparison of NK cells and alloreactive CTL responding to the same class I allotype will be made. In sum, the three aims will increase knowledge of the manner by which HLA class I polymorphisms control and individualize the cytolytic response to allogeneic transplants and cells compromised by virus infection or malignant transformation.

Agency
National Institute of Health (NIH)
Institute
National Institute of Allergy and Infectious Diseases (NIAID)
Type
Research Project (R01)
Project #
5R01AI022039-14
Application #
2886478
Study Section
Special Emphasis Panel (ZRG2-ALY (01))
Program Officer
Kehn, Patricia J
Project Start
1985-09-30
Project End
2001-06-30
Budget Start
1999-07-01
Budget End
2000-06-30
Support Year
14
Fiscal Year
1999
Total Cost
Indirect Cost
Name
Stanford University
Department
Biology
Type
Schools of Medicine
DUNS #
800771545
City
Stanford
State
CA
Country
United States
Zip Code
94305
Illing, Patricia T; Pymm, Phillip; Croft, Nathan P et al. (2018) HLA-B57 micropolymorphism defines the sequence and conformational breadth of the immunopeptidome. Nat Commun 9:4693
Pugh, Jason L; Nemat-Gorgani, Neda; Norman, Paul J et al. (2018) Human NK Cells Downregulate Zap70 and Syk in Response to Prolonged Activation or DNA Damage. J Immunol 200:1146-1158
Djaoud, Zakia; Guethlein, Lisbeth A; Horowitz, Amir et al. (2017) Two alternate strategies for innate immunity to Epstein-Barr virus: One using NK cells and the other NK cells and ?? T cells. J Exp Med 214:1827-1841
Hilton, Hugo G; Parham, Peter (2017) Missing or altered self: human NK cell receptors that recognize HLA-C. Immunogenetics 69:567-579
Hilton, Hugo G; Blokhuis, Jeroen H; Guethlein, Lisbeth A et al. (2017) Resurrecting KIR2DP1: A Key Intermediate in the Evolution of Human Inhibitory NK Cell Receptors That Recognize HLA-C. J Immunol 198:1961-1973
Blokhuis, Jeroen H; Hilton, Hugo G; Guethlein, Lisbeth A et al. (2017) KIR2DS5 allotypes that recognize the C2 epitope of HLA-C are common among Africans and absent from Europeans. Immun Inflamm Dis 5:461-468
Hilton, Hugo G; McMurtrey, Curtis P; Han, Alex S et al. (2017) The Intergenic Recombinant HLA-B?46:01 Has a Distinctive Peptidome that Includes KIR2DL3 Ligands. Cell Rep 19:1394-1405
Horowitz, Amir; Djaoud, Zakia; Nemat-Gorgani, Neda et al. (2016) Class I HLA haplotypes form two schools that educate NK cells in different ways. Sci Immunol 1:
Guethlein, Lisbeth A; Norman, Paul J; Hilton, Hugo G et al. (2015) Co-evolution of MHC class I and variable NK cell receptors in placental mammals. Immunol Rev 267:259-82
Hilton, Hugo G; Guethlein, Lisbeth A; Goyos, Ana et al. (2015) Polymorphic HLA-C Receptors Balance the Functional Characteristics of KIR Haplotypes. J Immunol 195:3160-70

Showing the most recent 10 out of 81 publications